Nanobodies are expanding their role in drug discovery for their small size, stability, and ability to target challenging proteins. However, their discovery typically relies on iterative, labor-intensive selection workflows. Emerging biosensor-based biopanning approaches provide more precise control over binding interactions, accelerating the identification of high-affinity candidates.
Download this application note to learn:
- How automated biopanning improves reproducibility and reduces nonspecific binding
- Strategies for enriching high-affinity nanobodies in fewer selection rounds
- Approaches to completing multiple panning cycles in shorter timelines
